Chemistry Services
Transforming therapeutic ideas into reality through cutting-edge chemistry.
Transforming therapeutic ideas into reality through cutting-edge chemistry.
We offer comprehensive chemistry services to expedite drug discovery and development, backed by experienced chemists and advanced facilities, ensuring the highest level of scientific and technical support, in alignment with global expectations outlined by the pharmaceutical development guidelines.
Zenovel’s Chemistry Service provide comprehensive support in medicinal and synthetic chemistry, enabling the development of innovative therapeutics from concept to clinic, leveraging the expertise and resources required for drug discovery and development.
Our chemists are highly skilled in medicinal and synthetic chemistry, ensuring the efficient progression of your drug candidates.
We utilize advanced technologies and methodologies to offer innovative solutions that are specifically tailored to your specific project requirements.
We foster a collaborative environment with clients to understand their goals and challenges, enhancing project success through close collaboration.
Our chemistry services are rigorously tested and regulated to ensure they meet the highest standards of excellence.
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.